Karolina Kuczapska

Karolina Kuczapska

Auto-generated profile, based on publicly available information

Karolina Kuczapska

University Clinical Hospital No. 4 in Lublin, Dr. Kazimierz Jaczewski 8 street, 20-954 Lublin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PMPaweł Moczydłowski
Paweł Moczydłowski
KKKarolina Kuczapska
Karolina Kuczapska
AGAnna Gliwa
Anna Gliwa
MRMonika Ryglewicz
Monika Ryglewicz
DFDariusz Fabian
Dariusz Fabian
KMKarolina Michalczuk
Karolina Michalczuk
This review discusses the epidemiology, pathophysiology, prevention and treatment of acute mountain sickness (AMS). Key mechanisms including changes in blood-brain barrier permeability, activation of the renin-angiotensin-aldosterone system and the role of diuresis in the development of AMS are analysed. The effectiveness of various preventive strategies, such as acclimatisation and pharmacotherapy (acetazolamide, dexamethasone, ibuprofen), as well as alternative approaches, including the use of natural remedies such as Rhodiola roses, coca leaves and Ginkgo biloba, are discussed. The paper emphasises the importance of correct diagnosis and prompt action in the treatment of AMS, which is crucial in preventing complications. Material and methods Data bases such as Pubmed and GoogleScholar were used for research with the key words: acute mountain illness (AMS), acetazolamid, dexametazone, altitude, prevention, acclimatisation. Conclusions Acute altitude sickness is a challenge in terms of understanding pathophyslogy and effective treatment methods. The primary methods of preventing AMS are properly managed acclimatisation and the use of acetazolamide. Other pharmacological and natural measures require further research.

6 March 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
NJNatalia Jakubczyk
Natalia Jakubczyk
ELElżbieta Leszczyńska-Knaga
Elżbieta Leszczyńska-Knaga
MKMarek Kurowski
Marek Kurowski
KKKarolina Kuczapska
Karolina Kuczapska
AGAnna Gliwa
Anna Gliwa
KMKarolina Michalczuk
Karolina Michalczuk
In recent years, wearable technology, including smartwatches, fitness bands, and smart rings, has become an integral part of health monitoring for patients with chronic diseases. These devices enable non-invasive, continuous tracking of key health parameters such as heart rate, glucose levels, sleep quality, and physical activity. This article analyzes their application in managing diabetes, cardiac arrhythmias, depression, and chronic obstructive pulmonary disease (COPD), highlighting their benefits in early detection of abnormalities and personalized healthcare. Research indicates that these tools significantly enhance treatment results while minimising the likelihood of complications and supporting patient self-management. Despite numerous advantages, such as increased patient engagement, this technology faces challenges, including data privacy and integration with healthcare systems. The conclusions point to the necessity for further development of wearable devices to ensure their broader implementation in clinical practice and patients’ daily lives.

5 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WRWeronika Rutkowska-Kawalec
Weronika Rutkowska-Kawalec
KMKarolina Michalczuk
Karolina Michalczuk
DFDariusz Fabian
Dariusz Fabian
MKMarek Kurowski
Marek Kurowski
ELElżbieta Leszczyńska-Knaga
Elżbieta Leszczyńska-Knaga
KKKarolina Kuczapska
Karolina Kuczapska
Introduction and objective:Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Early detection is crucial for better outcomes. Traditional diagnostic methods, such as imaging and biopsies, often fail to detect HCC in early stages. Liquid biopsy, based on circulating free DNA (cfDNA) analysis, offers a promising, non-invasive approach, allowing frequent testing, addressing tumor heterogeneity, and reducing costs. Review methods:This article's databases were accessed through the WHO website, PubMed, and Google Scholar. A brief description of the state of knowledge:Early detection of HCC significantly improves survival. Biomarkers from cfDNA, including DNA fragment patterns, methylation markers (e.g., USP44), 5-hydroxymethylcytosine (5hmC), and digital PCR analysis, have shown potential in early-stage detection. Advanced cfDNA fragmentomics identifies tumor-specific DNA fragmentation patterns. Techniques like DELFI demonstrate high sensitivity (94%) and specificity (98%). Machine learning enhances cfDNA analysis by integrating multiple markers, improving accuracy in distinguishing cancerous from precancerous states. Combining methylation analysis with machine learning further addresses challenges of tumor heterogeneity. Summary:Studies highlight the high sensitivity and specificity of cfDNA biomarkers for HCC diagnosis, especially in high-risk groups like individuals with cirrhosis. Integrating technologies like 5hmC analysis and machine learning enables early diagnosis and treatment monitoring. These advancements represent a transformative step in cancer diagnostics, offering effective tools to improve patient outcomes.

11 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MKMarek Kurowski
Marek Kurowski
KKKarolina Kuczapska
Karolina Kuczapska
AGAnna Gliwa
Anna Gliwa
MRMonika Ryglewicz
Monika Ryglewicz
DFDariusz Fabian
Dariusz Fabian
KMKarolina Michalczuk
Karolina Michalczuk
Introduction and purpose Prostate cancer is the most common malignant tumor in men in Poland. In 2021, the standardized incidence rate was 48.2 cases per 100,000 people. It is diagnosed mainly in men over 60 years of age. The choice of treatment method depends on the stage of the disease, general condition and age of the patient. Treatment mainly includes surgery, radiotherapy and hormone therapy. In the case of surgical procedures, it is possible to perform prostate cancer surgery using the Da Vinci single-port surgical robot. The aim of this literature review is to describe the procedure of radical prostatectomy using the da Vinci single-port robot and to assess the effectiveness of radical prostatectomy using the da Vinci single-port robot compared to open and laparoscopic prostatectomy. Material and methods This review of studies was based on articles obtained from the scientific database PubMed. Key search terms included prostate cancer; robot-assisted radical prostatectomy; robotic surgery; da Vinci Surgical System; da Vinci single-port; laparoscopic prostatectomy; open prostatectomy. Conclusions Currently, the da Vinci single-port surgical system is playing an increasingly important role in radical prostatectomy centers. It is increasingly replacing open radical prostatectomies due to its higher treatment efficacy and fewer complications. However, no significant differences have been demonstrated compared to classical laparoscopic surgery. Further studies are also necessary to assess functional and oncological results.

16 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AGAnna Gliwa
Anna Gliwa
MKMarek Kurowski
Marek Kurowski
KKKarolina Kuczapska
Karolina Kuczapska
MRMonika Ryglewicz
Monika Ryglewicz
DFDariusz Fabian
Dariusz Fabian
KMKarolina Michhalczuk
Karolina Michhalczuk
In an era of an aging population with the rise of social media, both men and women are paying more and more attention to the healthy appearance of their skin and overall health. Collagen is an essential component of the structure of the skin.With age, the amount of collagen in the skin decreases, there is a loss of elasticity as a result,wrinkles form and the appearance of the skin deteriorates. On the market there are more and more preparations both in the form of creams and means for oral application.One of the most popular dietary supplements that affect the quality of the skin and with tested bioavailability is hydrolyzed collagen . One can find many studies showing the positive effects of collagen supplementation on improving the quality and alleviating the visible signs of skin aging. In this review paper, we aim to evaluate the current state of knowledge of the effectiveness of hydrolyzed collagen supplementation on skin quality status. In order to investigate the efficacy and effects of hydrolyzed collagen for the skin, we need both preclinical studies, availability assessments and controlled clinical trials on a wide range of patients. Overall, it can be concluded that as little as 12 weeks of hydrolyzed fish collagen supplementation improves the quality and appearance of skin in the aging population.Importantly, HC-containing formulations were found to be safe and well-tolerated. However, further large-scale randomized controlled studies taking into account factors such as excipients in the supplements, age range and general lifestyle of the subjects are needed to confirm these results.

4 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KKKarolina Kuczapska
Karolina Kuczapska
MKMarek Kurowski
Marek Kurowski
AGAnna Gliwa
Anna Gliwa
MRMonika Ryglewicz
Monika Ryglewicz
DFDariusz Fabian
Dariusz Fabian
KMKarolina Michalczuk
Karolina Michalczuk
Introduction Obesity is a complex, chronic disease that continues to be a significant global health challenge due to its prevalence and association with numerous comorbidities. Etiology of this disease includes different factors from genetic, environmental, and lifestyle fields, while effective management of obesity is still being studied. Aim of the study The aim of this comprehensive review is to examine arising innovations in the treatment of adult obesity. Deeper insight into the available database would help to provide better understanding of obesity and of its treatment. Materials and Methods To reach satisfying results the research was conducted on the articles referring to obesity treatment from the Pubmed databases. Articles from recent years were preferably utilized to keep the review up to date. Results Nowadays, pharmacotherapy can offer GLP-1 receptor agonists like liraglutide or semaglutide, and new drugs like tirzepatide that show great effectiveness. Additionally, bariatric surgery continues to offer great solution for severe obesity, combining restrictive and malabsorptive mechanisms for significant weight loss and metabolic benefits. The main procedures include gastric bypass with sleeve gastrectomy or duodenal switch. Personalized treatment, referring to different obesity phenotypes, has shown improvement in the therapeutic outcomes. Some new therapies are studied including triple agonists (retatrutide), non-peptide GLP-1 receptor agonists, and drugs reaching other receptors. All of them are promising for the effective obesity treatment in the future. Summary This review underlines the need for multidisciplinary and personal approach in the treatment of obesity and the need to share the knowledge about it to address the growing obesity epidemic effectively. Recognizing obesity as a chronic and complex disease is essential to improve patient’s understanding of their condition as well as to reach effective treatment outcomes.